Skip to main content
Clinical Trials/IRCT138809032766N1
IRCT138809032766N1
Completed
Phase 3

Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women

Tarbiat Maodares University0 sites150 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
menopause.
Sponsor
Tarbiat Maodares University
Enrollment
150
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Tarbiat Maodares University

Eligibility Criteria

Inclusion Criteria

  • married, menopause after 40 years old and 12 months amenorrhea or 6 month amenorrhea and serum Estradiol less than 50 pg/dl.
  • Exclusion criteria: any history of active hepatitis, cardiovascular, inflamation disease (infectious or uninfectious), thoromboambolic or cerebrovascular disorder, psychosis, hyperlipidemia, history of chemotherapy or radiation, HRT treatment in previous 6 months, use of vitamine E, fluxitine, soymenopause,propranolol and another herbal or chemical druge, smoking, alchol or addiction

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials